Nuvalent Inc Class A
North American company
Times are shown in GMT-5, values are delayed by at least 15 minutes. Past performance is not a reliable indicator of future results.
Nuvalent Inc is a biopharmaceutical company focused on creating precisely targeted therapies for patients with cancer, designed to overcome the limitations of existing therapies for clinically proven kinase targets.
Latest NUVL News
Currently there are no news & analysis articles for this instrument. Visit our news hub for the latest investment news from ii and Alliance News